Corteva (CTVA) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 net sales rose 1% year-over-year to $6.1B, with operating EBITDA up 10% to $1.92B, driven by strong Seed performance and margin expansion, while Crop Protection faced ongoing pricing pressure and volume stabilization.
Seed business achieved record first half operating EBITDA, with broad-based pricing gains and market leadership in North America corn and soybeans, notably with Enlist E3 technology adoption.
Crop Protection volumes grew 6% in Q2, but the segment continued to face pricing headwinds and margin declines due to competition and destocking.
Royalty income grew 40% year-over-year in the first half, led by new corn trait technologies.
Shareholder returns included a 6–6.25% dividend increase and $1B in share repurchases planned for 2024, with $500M–$750M completed in the first half.
Financial highlights
Q2 2024 operating EBITDA margin improved to 31.4%, up 248–250 bps year-over-year; Seed margin at 39.2%, Crop Protection margin at 14.3%.
1H 2024 net sales were $10.6B, down 3% year-over-year, with operating EBITDA at $2.95B, slightly below prior year.
Seed net sales up 2% and organic sales up 4% in the half, with global Seed pricing up 5%.
Crop Protection net and organic sales down 11% in the half, with pricing down 4–5% and volumes down, but Q2 saw 6% volume growth.
Free cash flow guidance maintained at $1.5B–$2.0B for 2024.
Outlook and guidance
Full-year 2024 net sales expected at $17.2B–$17.5B (up 1% at midpoint); operating EBITDA at $3.4B–$3.6B (4% growth at midpoint); operating EPS at $2.60–$2.80, flat at midpoint.
Free cash flow projected at $1.5B–$2.0B; FCF/EBITDA conversion rate of 45–50%.
Dividend increased by 6–6.25%, with $1B in share repurchases planned for 2024.
Margin expansion expected, driven by Seed pricing and productivity, partially offset by Crop Protection pricing pressure.
Guidance does not include impacts from extreme weather, major operational disruptions, or further macroeconomic volatility.
Latest events from Corteva
- Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.CTVA
Proxy filing19 Mar 2026 - 2025 results delivered margin growth, strong governance, and pay aligned to performance and ESG.CTVA
Proxy filing19 Mar 2026 - Strong 2025 results and resilient nitrogen markets drive growth amid global and policy shifts.CTVA
Bank of America 2026 Global Agriculture and Materials Conference25 Feb 2026 - 2025 saw record margins, cash flow, and Bayer deal; 2026 set for further growth and separation.CTVA
Q4 20254 Feb 2026 - 2024 guidance reaffirmed as cost savings, innovation, and strong seed performance drive long-term growth.CTVA
Wells Fargo 2024 Industrials Conference1 Feb 2026 - Seed growth, cost control, and innovation drive outlook despite Argentina and weather headwinds.CTVA
BMO Ag-Apalooza Conference20 Jan 2026 - 2024 guidance narrowed as Q3 sales fell, but 2025 outlook targets strong EBITDA growth.CTVA
Q3 202415 Jan 2026 - Record 2024 margins and cash flow; 2025 targets 10% EBITDA growth and $1B buybacks.CTVA
Q4 20248 Jan 2026 - Q1 2025 operating EBITDA up 15% to $1.19B with margin gains; $1B buyback planned.CTVA
Q1 20258 Jan 2026